Capital World Investors Novo Cure LTD Put Options Transaction History
Capital World Investors
- $592 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.3MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$182 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$145 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$89.5 Million8.14% of portfolio
-
State Street Corp Boston, MA2.59MShares$42 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.7B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...